Briefs: Nasdaq to list BioSante stock
LINCOLNSHIRE -- BioSante Pharmaceuticals Inc. Tuesday said it has received notification from the Nasdaq Stock Market that its common stock is approved for listing on Nasdaq Global Market. BioSante's board of directors approved the decision to switch from The American Stock Exchange to Nasdaq. BioSante is going through the necessary regulatory process and expects to begin trading on Nasdaq under the symbol BPAX in early to mid-November.
NextWave partners with Kerr on iron
VERNON HILLS -- NextWave Pharmaceuticals and Kerr Drug have partnered on MyKidz Iron, a non-prescription liquid iron supplement that uses new suspension technology to deliver elemental iron without staining clothes or teeth. Stains and a highly bitter metallic taste are characteristics of liquid iron supplements that have traditionally kept compliance rates low. For information, visit www.mykidziron.com or call (866) 697-9283.